Page last updated: 2024-12-06

indium phosphide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Indium phosphide (InP) is a III-V semiconductor compound with a zinc blende crystal structure. It is known for its high electron mobility, direct bandgap, and good optical properties. InP can be synthesized using various methods, including the vertical gradient freeze technique, the liquid encapsulated Czochralski (LEC) method, and the vapor phase epitaxy (VPE) technique. InP is used in a wide range of applications, including high-speed transistors, lasers, photodetectors, and solar cells. It is studied extensively for its potential to improve the performance of these devices, as well as for its potential applications in quantum computing and optoelectronic devices. InP is also a promising material for use in high-power, high-frequency applications. '

indium phosphide: molecular formula - InP [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID31170
MeSH IDM0240133

Synonyms (37)

Synonym
indium phosphide
einecs 244-959-5
indium phosphide (inp)
indium monophosphide
hsdb 6935
indium(iii) phosphide, pieces, 3-20 mesh, 99.998% trace metals basis
22398-80-7
phosphinidyneindium
indiganylidynephosphane
dsstox_cid_11444
indium(iii) phosphide
cas-22398-80-7
NCGC00255118-01
dsstox_rid_78875
tox21_302280
dsstox_gsid_31444
unii-sd36lg60g1
sd36lg60g1 ,
ccris 8799
indium phosphide [mi]
indium phosphide [iarc]
DTXSID3031444
mfcd00016153
Q416291
indium(iii) phosphide, flakess, 3-20 mesh, 99.998% metals basis
indium(iii)phosphide
induim phosphide /zinc sulphide-peg- cooh quantum dots
induim phosphide /zinc sulphide-mpa-cooh quantum dots
indium phospide/zinc sulphide quantum dots
induim phosphide /zinc sulphide-peg-nh quantum dots
indium phospide/zinc sulphide
induim phosphide /zinc sulphide-mpa- cooh quantum dots
induim phosphide /zinc sulphide-peg-cooh quantum dots
induim phosphide /zinc sulphide-peg- nh quantum dots
inp/zns sulphide-peg-cooh
induim phosphide/zinc sulphide-peg-nh quantum dots
XAA39880

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" At concentrations at which no toxic effects can be observed, the functionality of the QDots for fluorescence cell visualization is evaluated, revealing that the higher brightness of QDotZnSe overcomes most of the toxicity issues compared to that of QDotInP."( Cytotoxicity of cadmium-free quantum dots and their use in cell bioimaging.
Aubert, T; Braeckmans, K; De Smedt, SC; Demeester, J; Hens, Z; Himmelreich, U; Manshian, BB; Soenen, SJ, 2014
)
0.4
" In addition, these differences in toxicity were observed despite the two particulate compounds containing similar amounts of indium suggesting that solubilization, not total indium content, better reflects the toxic potential of some ICPs."( Macrophage solubilization and cytotoxicity of indium-containing particles as in vitro correlates to pulmonary toxicity in vivo.
Bousquet, RW; Gwinn, WM; Morgan, DL; Price, H; Qu, W; Shines, CJ; Taylor, GJ; Waalkes, MP, 2015
)
0.42

Bioavailability

ExcerptReferenceRelevance
" Indium was poorly absorbed from the gastrointestinal tract in both single and multiple oral dose studies."( Tissue distribution and elimination of indium in male Fischer 344 rats following oral and intratracheal administration of indium phosphide.
Carter, DE; Kattnig, MJ; Sipes, IG; Winter, SM; Zheng, W, 1994
)
0.5

Dosage Studied

ExcerptRelevanceReference
" The biodistribution, body weight, hematology, blood biochemistry, and organ histology were determined at a very high dosage (25 mg/kg) of InP/ZnS QDs over 84 days period."( In vivo toxicity assessment of non-cadmium quantum dots in BALB/c mice.
Chen, Q; Ding, Z; Hu, R; Lin, G; Ouyang, Q; Tian, J; Wang, X; Xu, G; Yin, F; Yong, KT, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency0.79640.002541.796015,848.9004AID1347395
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (164)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (2.44)18.2507
2000's56 (34.15)29.6817
2010's92 (56.10)24.3611
2020's12 (7.32)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 88.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index88.21 (24.57)
Research Supply Index5.12 (2.92)
Research Growth Index5.82 (4.65)
Search Engine Demand Index153.32 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (88.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other167 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]